Inhibition of T cell activation by normal human biliary epithelial cells

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 1026-1033

  Cruickshank, Sheena M ^a   Southgate, Jennifer ^a   Selby, Peter J ^a   Trejdosiewicz, Ludwik K ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Biliary epithelial cells; Flow cytometry; Interferon ; T cell activation; TGF

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; TRANSFORMING GROWTH FACTOR BETA;

ACCESSORY CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FLOW CYTOMETRY; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0032731749     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80315-8     Document Type: Article

References (42)

1. Cruickshank S, Southgate J, Selby P, Trejdosiewicz L. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial cells and established liver cell lines. J Hepatol. 29:1998;550-558.
2. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut. 34:1993;1245-1249.
3. Kvale D, Brandtzaeg P. Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines. J Hepatol. 17:1993;347-352.
4. Leon MP, Kirby JA, Gibbs P, Burt AD, Bassendine MF. Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules. J Hepatol. 22:1995;591-595.
5. Tsuneyama K, Van de Water J, Leung PSC, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology. 21:1995;1031-1037.
6. Spengler U, Leifeld L, Braunschweiger I, Dumoulin FL, Lechmann M, Sauerbruch T. Anomalous expression of costimulatory molecules B7-1, B7-2 and CD28 in primary biliary cirrhosis. J Hepatol. 26:1997;31-36.
7. Nakanuma Y, Yasoshima M, Tsuneyama K, Harada K. Histopathology of primary biliary cirrhosis with emphasis on expression of adhesion molecules. Semin Liver Dis. 17:1997;35-47.
8. Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study. J Pathol. 186:1998;126-130.
9. Gordon J. CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Reviews. 9:1995;53-56.
10. Grewal IS, Flavell RA. The CD40 ligand. At the center of the immune universe? Immunol Res. 16:1997;59-70.
11. Klaus SJ, Berberich I, Shu G, Clark EA. CD40 and its ligand in the regulation of humoral immunity. Semin Immunol. 6:1994;279-286.
12. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today. 15:1994;406-411.
13. Stout RD, Suttles J. The many-roles of CD40 in cell-mediated inflammatory responses. Immunol Today. 17:1996;487-492.
14. Leon MP, Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology. 112:1997;968-977.
15. + T cells. Hepatology. 24:1996;561-567.
16. Scholz M, Gooss A, Blaheta RA, Encke A, Markus BH. Cultured human biliary epithelial cells induce allogeneic lymphocyte activation in vitro: possible relevance in liver transplant rejection. Immunol Letters. 55:1997;27-34.
17. Bal V, McIndoe A, Denton G, Hudson D, Lombardi G, Lamb J, et al. Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol. 20:1990;1893-1897.
18. Lombardi G, Arnold K, Uren J, Marelli-Berg F, Hargreaves R, Imami N, et al. Antigen presentation by interferon-gammatreated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur J Immunol. 27:1997;62-71.
19. + T cells. J Immunol. 159:1997;5853-5861.
20. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology. 21:1995;113-119.
21. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol. 105:1996;254-259.
22. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis. 17:1997;115-123.
23. Joplin R, Strain AJ, Neuberger JM. Immuno-isolation and culture of biliary epithelial cells from normal human liver. In Vitro Cell Dev Biol. 25:1989;1189-1192.
24. Strain AJ, Wallace L, Joplin R, Daikuhara Y, Ishii T, Kelly DA, et al. Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol. 146:1995;537-545.
25. Rowbotham DS, Howdle PD, Trejdosiewicz LK. Peripheral cellmediated immune response to mycobacterial antigens in inflammatory bowel disease. Clin Exp Immunol. 102:1995;456-461.
26. Sillett HK, Whicher J, Trejdosiewicz LK. Effects of resuscitation fluids on T cell immune responses. Br J Anaesth. 81:1998;242-243.
27. Naylor JR, James SR, Trejdosiewicz LK. Intracellular free Ca2+ fluxes and responses to phorbol ester in T lymphocytes from healthy elderly subjects. Clin Exp Immunol. 89:1992;158-163.
28. Foster PN, Trejdosiewicz LK. Impaired proliferative responses of peripheral blood B cells from splenectomized subjects to phorbol ester and ionophore. Clin Exp Immunol. 89:1992;369-373.
29. Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1-20.
30. Marelli-Berg FM, Hargreaves REG, Carmichael P, Dorling A, Lombardi G, Lechler RI. Major Histocompatibility Complex Class II-expressing endothelial cells induce allospecific nonresponsiveness in naive T cells. J Exp Med. 183:1996;1603-1612.
31. Wilson JL, Proud G, Forsythe JL, Taylor RM, Kirby JA. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody. Transplantation. 59:1995;91-97.
32. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 149:1993;315-330.
33. Agrawal B, Krantz M, Reddish M, Logenecker B. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med. 4:1998;43-49.
34. Vandenhaute B, Buisine MP, Debailleul V, Clément B, Moniaux N, Dieu MC, et al. Mucin gene expression in biliary epithelial cells. J Hepatol. 27:1997;1057-1066.
35. Barrett TA, Tatsumi Y, Bluestone JA. Tolerance of T cell receptor gamma/delta cells in the intestine. J Exp Med. 177:1993;1755-1762.
36. Cunningham AC, Zhang JG, Moy JV, Ali S, Kirby JA. A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology. 91:1997;458-463.
37. Gimmi CD, Morrison BW, Mainprice BA, Gribben JG, Boussiotis VA, Freeman GJ, et al. Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells. Nat Med. 2:1996;1367-1370.
38. L expression. Immunology. 89:1996;397-404.
39. + T cells is dependent on B7 (CD80), augmented by CD58, but relatively uninfluenced by CD54 expression. Int Immunol. 7:1995;1505-1513.
40. Lombardi G, Sidhu S, Batchelor R, Lechler R. Anergic T cells as suppressor cells in vitro. Science. 264:1994;1587-1589.
41. Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, et al. Involvement of CD40 ligand CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J Immunol. 160:1998;4225-4231.
42. Karmann K, Hughes CC, Fanslow WC, Pober J. Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-1 signaling pathway. Eur J Immunol. 26:1996;610-617.